Macrophage/monocyte depletion

Macrophage/monocyte depletion has been studied in 1 paper since 2026: none in people yet, 1 in animals; 1 in the past year. The research so far is in animals. The newest story, Oct 22, 2026: “Statins plus an immune-cell molecule killed kidney cells”.

Intervention

1 paper studies it1 findingUpdated

  • 1 lab
  • Animals1

What did studies of Macrophage/monocyte depletion find?

1

Studies of Macrophage/monocyte depletion measured 1 outcome; the most studied are acute kidney injury (1 study).

Acute kidney injury

downin mice1

1 study
  1. Macrophage/monocyte depletion decreases acute kidney injury in mice.

    “AKI was attenuated by mevalonate supplementation, which restored protein prenylation, and by macrophage/monocyte depletion”

    Animalsstatin-associated acute kidney injurykidney

    Statins plus an immune-cell molecule killed kidney cells

    bioRxivPreprint

More on Acute kidney injury

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 11 paper in 12 months
bioRxiv

Statins plus an immune-cell molecule killed kidney cells

In kidney cell experiments, atorvastatin and fluvastatin caused cell death when combined with 25-hydroxycholesterol, a cholesterol derivative made by activated immune…In kidney cell experiments, atorvastatin and fluvastatin caused cell death when combined with 25-hydroxycholesterol, a cholesterol derivative made by activated immune cells.

Preprint: cell studyKidney